News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neurotez, Inc. Awarded Multi-Million Dollar National Institutes of Health (NIH) Grant to Advance a Leptin Product into Clinical Trials for Treating Alzheimer's Disease



8/4/2009 10:03:42 AM

BRIDGEWATER, N.J.--(BUSINESS WIRE)--The National Institutes of Health (NIH), through the Small Business Innovation and Research (SBIR) Program, has awarded Neurotez, Inc. a $2.73-million dollar, three-year grant to initiate the clinical development of a Leptin product as a novel therapy for Alzheimer’s disease. Leptin, a naturally occurring human hormone associated with various metabolic effects, has a large number of receptors in memory centers of the brain and is often decreased in patients with Alzheimer’s disease. The Neurotez approach is based on restoration of Leptin levels.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES